New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 5 (3-4) , 119-125
- https://doi.org/10.1016/s1368-7646(02)00051-1
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in SpainAntimicrobial Agents and Chemotherapy, 2002
- Mutation frequency and biological cost of antibiotic resistance in Helicobacter pyloriProceedings of the National Academy of Sciences, 2001
- Glycylcyclines: third-generation tetracycline antibioticsPublished by Elsevier ,2001
- Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial ResistanceMicrobiology and Molecular Biology Reviews, 2001
- In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000
- Research and development of antibacterial agentsCurrent Opinion in Microbiology, 1998
- In-vitro activity of two glycylcyclines against enterococci resistant to other agentsJournal of Antimicrobial Chemotherapy, 1995
- "Glycylcyclines". 3. 9-AminodoxycyclinecarboxamidesJournal of Medicinal Chemistry, 1994
- In vitro activities of two glycylcyclines against gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1994